due to lower prices. Net debt to equity is at 0.99 times, well below IVL’s covenants, and supported by stronger operating cash flow. The dividend payout of THB 1.225/share for 2019 remains higher than
, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the
1,921 million decreased by 7% compared to the previous year. It derived from: • Revenues from sales and services of medical device business for the year 2019 were Baht 1,798 million decreased by 3% in
% -2.4% Prepaid 113 92 86 -24% -6.5% Blended 138 118 112 -19% -5.1% VOU (GB/data sub/month) Postpaid 14.4 16.6 17.0 18% 2.3% Prepaid 10.3 11.1 13.8 34% 23% Blended 11.4 12.7 14.7 29% 16% Device Penetration
appropriate by Dhipaya Bodin as a joint venture. It will benefit potential shareholders in the medical device and distribution business. The current production and distribution line is Blood Line with a
% Blended 18.0 22.6 24.9 38% 10% Device Penetration 4G-handset penetration 77% 81% 80% - - Fixed Broadband Business FBB subscribers 1,336,900 1,668,900 001,772, 0 33% 6.2% FBB net addition 81,400 133,000
. Customers were required to commit to a certain price plan to improve ARPU level through data and device bunding packages. Meanwhile, there were campaigns and offerings in prepaid segment at a minimal scale
lower network traffic with TOT and change in IC rate effective from Jan- 22. Device & SIM card sales reported Bt9,270mn, decreasing -4.3% YoY and -32% QoQ. QoQ drop was mainly from high seasonal sales of
payout ratio8 % 80.79 97.77 309.91 Interest Bearing Debt to equity ratio9 times 1.39 1.38 2.04 Specific Ratio for Our Business1 Cash collection from NPL management business to net NPLs10 % 12.83 14.55